Contribution of biopharmaceutics and pharmacokinetics to improve drug therapy A. Domínguez-Gil OriginalPaper Pages: 1 - 5
Perspectives of in vitro dissolution tests in establishing in vivo/in vitro correlations M. Siewert OriginalPaper Pages: 7 - 18
Pharmacokinetic studies in healthy volunteers in the context of in vitro/in vivo correlations B. OosterhuisJ. H. G. Jonkman OriginalPaper Pages: 19 - 30
Integration of animal pharmacokinetic and pharmacodynamic data in drug safety assessment D. A. Smith OriginalPaper Pages: 31 - 39
Pharmacokinetic-pharmacodynamic modelling in pre-clinical investigations: principles and perspectives M. DanhofJ. W. MandemaR. A. A. Mathôt OriginalPaper Pages: 41 - 47
Pharmacokinetic-pharmacodynamic relationships in Phase I/Phase II of drug development A. Van PeerE. SnoeckJ. Heykants OriginalPaper Pages: 49 - 59
Pharmacokinetic and pharmacodynamic data and models in clinical trials J. L. SteimerM. E. EbelinJ. Van Bree OriginalPaper Pages: 61 - 76
Pharmacokinetics of endogenous substances: Some problems and some solutions A. MarzoA. Rescigno OriginalPaper Pages: 77 - 88
Identification of populations at risk in drug testing and therapy: Application to elderly patients W. A. Ritschel OriginalPaper Pages: 101 - 111
In vitro/in vivo correlations: Scientific implications and standardisation J. M. CardotE. Beyssac OriginalPaper Pages: 113 - 120
In vitro/in vivo correlations in biopharmaceutics: scientific and regulatory implications J. P. SkellyG. F. Shiu OriginalPaper Pages: 121 - 129
